// App-Quantinova.ai

P376 : CD38: A FUNCTIONING TARGET IN RELAPSED/REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA. LIMITATIONS IN TREATMENT AND DIAGNOSTICS.

Researchers

Presenter

  • Barbora Vakrmanova

Principal Investigators

  • Michaela Novakova

  • Petr Riha

  • Marketa Zaliova

  • Eva Fronkova

  • Ester Mejstrikova

  • Jan Stary

  • Ondrej Hrusak

  • Lucie Sramkova

Medical Centers

  • Department of Paediatric Haematology and Oncology,CLIP, Second Faculty of Medicine and Motol University Hospital,Pragu

  • Department of Paediatric Haematology and Oncology,CLIP, Second Faculty of Medicine and Motol University Hospital,Pragu

  • Depart

  • Department of Paediatric Haematology and Oncology,CLIP, Second Faculty of Medicine and Motol University Hospital,Prague,Tschechische Republik

  • Department of Paediatric Haematology and Oncology,CLIP, Second Faculty of Medicine and Motol University Hospital,Pragu

  • Department of Paediatric Haematology and Oncology,CLIP, Second Faculty of Medicine and Motol University Hospital,Pragu

  • Department of Paediatric Haematology and Oncology,CLIP, Second Faculty of Medicine and Motol University Hospital,Pragu

Locations

  • Czech Republic

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • T-cell acute lymphoblastic leukemia

Biomarkers

  • Cluster of Differentiation 38

Drug/Treatment

  • daratumumab Intravenous

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved